FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Ascend Laboratories Quetiapine Tablets 400 mg Recall

Quetiapine Tablets USP 400 mg, 100 tablet bottles, Rx Only, Manufactured by: Alkem Lab…

Ascend Laboratories LLC · Parsippany, NJ

Risk level
Class II
Reported by FDA
Dec 5, 2018
Recall ID
D-0287-2019
Check your lot numberHow we source this data

Summary

Ascend Laboratories recalled Quetiapine Tablets 400 mg starting Nov 14, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0287-2019 on Dec 5, 2018. Reason: Presence of Foreign Substance; metal shard found in tablet. Status: Terminated.

Why it was recalled

Presence of Foreign Substance; metal shard found in tablet

Product description

Quetiapine Tablets USP 400 mg, 100 tablet bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India. Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 --- NDC 67877-248-01, UPC code: 3 67877-248-01 1

Lot numbers, UPCs & expiration codes

Lot 7143908, exp Nov 2020

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0287-2019
Classification
Class II
Status
Terminated
Recall initiated
Nov 14, 2018
FDA report date
Dec 5, 2018
Quantity
N/A
Recall type
Voluntary: Firm initiated
Recalling firm
Ascend Laboratories LLC

Original FDA data

Every field from FDA enforcement report D-0287-2019, exactly as published.

Show all FDA fields
City
Parsippany
State
NJ
Status
Terminated
Country
United States
Event ID
81568
Address
339 Jefferson Rd Ste 101
Code information
Lot 7143908, exp Nov 2020
Postal code
07054-3707
Report date
Dec 5, 2018
Product type
Drugs
Recall number
D-0287-2019
Classification
Class II
Recalling firm
Ascend Laboratories LLC
Termination date
Mar 30, 2020
Reason for recall
Presence of Foreign Substance; metal shard found in tablet
Voluntary / mandated
Voluntary: Firm initiated
Product description
Quetiapine Tablets USP 400 mg, 100 tablet bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India. Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 --- NDC 67877-248-01, UPC code: 3 67877-248-01 1
Distribution pattern
Nationwide
Recall initiation date
Nov 14, 2018
Initial firm notification
Letter
Center classification date
Nov 28, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0287-2019, published Dec 5, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls